Rationale: Rapid response by health-care systems for transient ischemic attack and minor stroke (TIA/mS) is recommended to maximize the impact of secondary prevention strategies. The applicability of this evidence to Australian non-hospital-based TIA/mS management is uncertain.
Introduction and rationale
Transient ischemic attack and minor stroke (TIA/mS) comprise approximately 40% of all episodes of brain ischemia 1, 2 and carry a significant risk of disabling or fatal stroke. 3 Much of the stroke risk occurs very early after TIA/mS 4 and rapid specialist assessment and intervention has been shown to reduce this risk. 5, 6 Therefore a rapid response within the system of care for TIA/mS is required to maximize the impact of secondary prevention strategies. 6, 7 Based on this international evidence, current Australian guidelines recommend universal rapid-access to specialist care. 8 There are uncertainties regarding compliance with these guidelines and with the applicability of the current evidence and guidelines to the contemporary management of TIA/mS in Australia beyond the hospital secondary care setting.
Rapid-access acute neurovascular clinics, one preferred model, 6 were only available in 38% of Australian hospitals in 2015 9 compared with 98% of UK hospitals 2010. 10 Even in Australian areas with rapid-access clinics, service utilization is uncertain. Extrapolation of figures for populations served 11, 12 and TIA/mS seen 4,13 in acute neurovascular clinics in Oxfordshire and the Hunter region of Australia (where TIA/mS are infrequently admitted to hospital) suggest that the majority of TIA/mS in this Australian region are not referred for rapid-access management. Thus it is not clear if improvements in TIA/mS outcomes evident in regions with more ready access to stroke specialist care 7 are applicable to health systems such as Australia's.
There are uncertainties concerning TIA/mS management and compliance with national guidelines in Australia. These include: 
Methods

Design
InSIST is an inception cohort study in which patients with possible TIA/mS were followed for 12 months post-index event. InSIST records patients' outcomes and their interactions with health-care systems.
Patient population
Participants were recruited from the Hunter and Manning valleys regions of New South Wales, within the referral territory of the Acute Neurovascular Clinic (ANVC) at the John Hunter Hospital (the major teaching and referral hospital of the Hunter New England Local Health District). These patient participants attended one of 16 general practices within the 
Recruitment, detailing, and further engagement of general practices
Practices were recruited by initial contact with individual GPs, the sampling frame being the membership list of the Hunter Medicare Local, a comprehensive list of GPs in the Hunter region. Subsequent recruitment processes were adapted to variability in practice size, organization, governance, and processes across the region. A requirement of recruitment was that the practice assigns a practice nurse to work on the study.
Once a practice agreed to participate in the study, a study investigator (PM) visited the practice to orient the designated study practice nurse to the project. The study research manager (DQ) then visited the practice to deliver comprehensive study procedures training to the study practice nurse, including ascertainment strategies and data collection procedures.
Awareness of the study and of methods was maintained with regular visits to recruiting practices by study investigators (CL, PM, DL) and periodic meetings with participating practice nurses where the progress of the study was reviewed, organizational issues were discussed, and clinical education on recognition of difficult TIA/mS scenarios was provided.
Ascertainment of events and recruitment of patients
The study aimed to recruit all patients with possible TIA/mS to ensure full case ascertainment. All patients where the attending GP considered TIA/mS a possible diagnosis were invited to participate. This strategy reflects the ''real world'' clinical difficulty for GPs in distinguishing TIA/mS from mimics 16 and evidence that the incidence of transient neurological symptoms in the population is substantially greater than the specialist-diagnosed incidence of TIA in hospital-based and population-based studies. 17, 18 Furthermore, there is evidence of variation in the description of TIA/mS features. Less conventional features of presentation are increasingly noted to be important where ''the physical phenotype of stroke that is used as the basis for clinical description of TIA may not capture all of the available diagnostic information''. 19 Patients were identified as potential entrants to the study cohort by multiple overlapping methods (see Appendix 1) .
Study participant inclusion and exclusion criteria are detailed in Appendix 2.
Recruitment of patients was undertaken from August 2012 to June 2016. Recruitment procedures are detailed in Appendix 3.
Data collection
As far as possible data collected was harmonized with the Oxford (UK) and Auckland (New Zealand) based Oxford Vascular Study (OXVASC) 20 and Auckland Regional Community Stroke Study (ARCOS) 21 studies to enable international comparisons of systems of care for TIA/mS. Participant data. Participants underwent baseline interview and follow-up interviews at three-and 12-months post-baseline assessment. The interviews were either via phone or home-visit, depending on the participant's functional status. For details of participant data collected, see Appendix 4.
Following collection of baseline data, index events were adjudicated as stroke, TIA, or a TIA/mS mimic. The adjudication panel consisted of three medical clinicians, at least one of which was a stroke physician and at least one of which was a GP. The adjudication panel assessed available information on the participant and on the index event, including the participant and witness narratives of events, past medical history/vascular risk factors, medications, imaging and other test results, general practice consultation notes, referral letters, specialist consultation notes, and emergency department or hospital discharge letters.
The nature of each TIA/mS mimic was adjudicated, as was the territory of the TIA/mS or mimic, e.g. anterior (cortical, subcortical, retinal, uncertain) or posterior circulation. If the participant was adjudicated to have had a TIA/mS, the likely mechanism was determined using the TOAST classification. 22 Practice data. Practice data collected included practice size (both individual and full-time-equivalent GP numbers), rurality/urbanicity index of the practice, 23 after-hours care arrangements, practice GP staffing arrangements in the local hospital, and distance from the practice to the ANVC. International Journal of Stroke, 14 (2) 2. That rural dwelling, lower socio-economic status (SES) and advancing age will be associated with lower rates of referral to specialist care. 3. That specialist care will demonstrate greater adherence to guideline-recommended investigation and management in comparison to exclusive GP management specifically for: a. Brain imaging b. Vascular imaging c. Immediate anti-platelet, blood pressure, and statin therapy. 4. That referral to specialist care will result in lower recurrent vascular event rates. 5. That referral to specialist care will result in greater quality of life. 6. That rates of recurrent vascular events will be lower than those in the international cohorts. 7. That rates of recurrent vascular events will be higher in lower SES bands. 8. That the processes of care (time from event to presentation, time from presentation to referral to secondary care, time to secondary care assessment) will be associated with a. Risk stratum (ABCD2); (b) patient factors (age, SES status, risk factors and co-morbidities); (c) practice factors (geographical location, size of practice, out-of-hours care arrangements).
Outcome measures
The process and clinical outcomes were determined. 
Analyses and sample size calculations
The Hunter region population in 2011 was 620,530.
11
For reference, the OXVASC study is conducted across a population of 91,000 individuals registered with nine Oxfordshire general practices and 63 GPs. The OXVASC catchment ascertains approximately 100 neurologist-adjudicated TIA and 100 minor stroke cases per annum. 4, 20, 25, 26 In the Hunter region, with a ratio of population to full-time equivalent (FTE) GPs of 1500:1, and allowing for a participation response rate of 60%, we needed to recruit practices containing approximately 51 FTE GPs to recruit 100 TIA/mS per year (and, thus 400 TIA/mS during the study period).
See Appendix 5 for planned analytical methods and associated sample size calculations.
Summary and conclusions
InSIST is an inception cohort study addressing the interactions of TIA/mS patients with health-care systems, including the primary-secondary care interface, and the outcomes of TIA/mS in a community-based sample. It compares processes of care and outcomes in three countries and provides data on which to base context-appropriate TIA/mS management guidelines for Australian practice.
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